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MinireviewMethylated Cytosine and the Brain:
A New Base for Neuroscience
lencing of genes (Figure 1; Jones et al., 1998; Nan et
al., 1998). Dozens of mutations have been identified in




of the most common genetic causes of mental retarda-4058 Basel
tion in females. Patients appear normal for the first 6–18Switzerland
months of life, then rapidly degenerate, suffering from
severe dementia and autistic behavior (references in
Chen et al., 2001). The disease follows a slow progres-
Methylation of genomic CpG residues is crucial for sion involving truncal ataxia, loss of intentional hand
proper neuronal function. Rett syndrome, a common use, stereotypical hand movements, and a high inci-
form of mental retardation, is associated with muta- dence of epilepsy. Examination of the brain revealed
tions in the gene encoding MeCP2, a methyl CpG bind- no evidence of tissue degeneration, but a pronounced
ing protein linked to transcriptional repression. Gene microcephaly, caused at least in part by a decrease in
knockouts of mouse Mecp2 have reproduced key as- neuronal cell size and an increase in packing density.
pects of the disease. A CNS-restricted knockout of MeCP2 is an X-linked gene that undergoes X chromo-
Dnmt1, encoding the enzyme that maintains CpG some inactivation, so heterozygous mutant females are
methylation patterns, results in loss of mutant neurons functionally mosaic for the mutation. However, this mo-
and glia. saicism is not evident in postmortem examination of
brain tissue, which revealed a uniform reduction in the
length and complexity of dendritic branching in neuronsIn the genome of many eukaryotes, cytosine residues
of layers III and V of frontal and motor cerebral cortexare covalently modified by the addition of a methyl group
(Armstrong et al., 1998). Such reductions were seen in allpreferentially, but not exclusively, at the sequence CpG.
examined neurons, suggesting a non-cell-autonomousIn mammals, 60%–90% of CpG sites are methylated,
effect of the mutation. Rett mutations comprise twoand most of the remaining unmethylated residues are
varieties: missense mutations occurring mostly in theclustered in CpG islands within functional gene promot-
amino-terminal methyl CpG binding domain (MBD), anders. Changes in methylation status can result in pro-
nonsense mutations, which are predicted to cause pro-found changes in gene expression, mostly in which
tein truncations mostly 3 to the MBD in the transcrip-methylation correlates with an inactive transcriptional
tional repression domain (TRD; reviewed in Van denstatus. Methylated CpG residues are specifically recog-
Veyver and Zoghbi, 2000). Recombinant MeCP2 pro-nized by a small family of transcriptional repressors,
teins bearing missense mutations in the MBD have beenwhich upon binding can recruit members of chromatin
shown in vitro to lose the ability to bind methylated DNAremodeling complexes, leading to transcriptional inacti-
(Yusufzai and Wolffe, 2000). Recently, Wan et al. (2001)vation after the deacetylation of core histone proteins
examined fibroblasts from Rett patients bearing two of(reviewed in Robertson and Wolffe, 2000). In mouse and
the more common truncation mutations and showedXenopus, disruption of normal genomic methylation pat-
that the acetylation of histone H4 was increased, asterns radically disturbs development after gastrulation,
would be expected for mutants lacking the TRD.leading to apoptosis throughout the embryo (Stancheva
MeCP2 is ubiquitously expressed in human andet al., 2001, and references therein). Although years of
mouse; are the neurological defects seen in Rett patientsin vitro experiments suggested a role for DNA methyla-
caused exclusively by defects in the CNS? Also, is thetion in the tissue-specific regulation of gene expression,
delay of onset of the disease indicative of a destabiliza-the embryonic lethality seen in the aforementioned ex-
tion in postnatal neuronal function or the delayed ap-periments prevented an investigation of its relevance in
pearance of a developmental defect? The laboratoriesvivo. Bringing together complementary genetic ap-
of Bird and Jaenisch (Guy et al., 2001; Chen et al., 2001)proaches in human and the mouse, reports in the past
present mouse models of Rett syndrome that answer2 years have revealed that methylated cytosine repre-
both of these questions. In both studies, protein-codingsents a new base for neuroscience in the study of neu-
exons of the Mecp2 gene were engineered with flankingronal stability, morphology, and function.
bacterial loxP sites, so that Mecp2 could be eliminated
As in all other parts of the body, mammalian genomic
through recombination after expression of Cre recombi-
DNA in the brain is methylated throughout life, and brain
nase. Ubiquitous deletion of Mecp2 resulted in mice that
extracts contain methyltransferase activity. The first in- appeared normal until several weeks of age, when they
dication that DNA methylation could be important for developed neurological abnormalities such as abnormal
the central nervous system (CNS) was unexpectedly gait and reduced activity. As with Rett syndrome pa-
provided by the protein MeCP2. MeCP2 binds to individ- tients, the mice display microcephaly and smaller neu-
ual methylated CpG residues, and it has been shown to ronal size (Chen et al., 2001); however, all homozygous
recruit members of chromatin remodeling complexes, mutants died within several months. Amazingly, hetero-
such as the transcriptional repressor Sin3A and the his- zygous mutant females, as in humans, developed inertia
tone deacetylases HDAC1 and HDAC2 to effect the si- and ataxic-like symptoms 6 months after birth, despite
the huge difference in developmental time scales be-
tween the two species. By crossing to a strain of mice1 Correspondence: klt@fmi.ch
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Figure 2. A Requirement for Genomic Methylation in the CentralFigure 1. Murine Mecp2 Knockout Reproduces Aspects of Rett
Nervous SystemSyndrome
(A) Cytosine is preferentially methylated (asterisk) at CpG residues inMeCP2 specifically binds methylated CpG residues (asterisks indi-
genomic DNA, and this methylation pattern is faithfully reproducedcate methyl groups). The transcriptional repression domain of
during DNA replication (S) by the action of DNA methyltransferaseMeCP2 recruits Sin3A and histone deacetyltransferases (HDAC1/2)
1 (Dnmt1, orange circle), which shows a preference for hemimeth-to affect transcriptional repression (X) of an unidentified group of
ylated DNA.target genes. In the Mecp2 knockout, Rett syndrome-like pheno-
(B) Dnmt1 is highly expressed in neurons, a postmitotic population.types are possibly caused by aberrant transcription (?) of these
A loss of Dnmt1 in proliferating neuronal precursors (nestin) gener-target genes.
ates highly demethylated neurons and glia that are rapidly eliminated
postnatally. In contrast, loss of Dnmt1 in neurons in the forebrain,
hippocampus, and brainstem leads to no demethylation and noexpressing Cre recombinase from the nestin promoter/
apparent phenotype.enhancer, both laboratories were able to produce mu-
tants in which almost all CNS neurons and glia were
missing Mecp2. These mice developed identical symp- MeCP1 histone deacetylase complex, another chroma-
tin-remodeling complex implicated in transcriptional re-toms in the same time frame as the complete mutants.
The Jaenisch laboratory used, in addition, a mouse pression (Ng et al., 1999). Interestingly, the Mbd2 knock-
out also showed a behavioral phenotype, in that mutantexpressing Cre recombinase from the Cam kinase pro-
moter, to affect a knockout of Mecp2 throughout the mothers did not adequately feed their young (Hendrich
et al., 2001). With respect to the Rett-like phenotype,brain but exclusively in postmitotic neurons. In these
animals, similar neurological phenotypes were ob- double mutant animals showed identical symptoms and
mortality as the Mecp2 knockout alone, and no newserved, including an ataxic gait, reduced activity, and a
decrease in brain weight and neuronal size. Although obvious defects. Mbd1, 2, and 3 are expressed through-
out the body, but any full explanation of possible func-these phenotypes developed at later time points, this
restricted knockout clearly demonstrates that the Rett- tional redundancy must be predicated on the basis of
spatiotemporal expressional profiles, which are notablylike phenotypes originate exclusively from a neuronal
deficit of Mecp2, which leads to a disturbance in their lacking for these genes.
Rett syndrome could also reflect a particular sensitiv-postnatal function. The correlate question is of course
then raised: why should a ubiquitous loss of Mecp2 ity of neurons to methylation-dependent transcriptional
repression. A separate line of evidence suggests thatexhibit a phenotype primarily in the CNS? The specificity
of the Mecp2 knockout phenotype could reflect a lack genomic methylation must be tightly controlled for neu-
rons to survive. CNS neurons demonstrate extremelyof complementation by other methyl-CpG binding pro-
teins in the brain. Mbd1, 2, and 3 are three other mem- high levels of expression of Dnmt1 (Inano et al., 2000),
which encode a maintenance methyltransferase show-bers of the Mecp2 family (references in Hendrich et al.,
2001), and Bird’s group addressed the possibility of ing a preference for the hemimethylated DNA substrates
seen directly after replication of genomic DNA (Figurefunctional redundancy by crossing the Mecp2 knockout
mouse to a strain lacking Mbd2. Mbd2 acts as a tran- 2A). Dnmt1 activity is known to be spatially and tempo-
rally coupled to DNA replication sites in cycling cells, soscriptional repressor in vitro and copurifies with the
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it is puzzling why it should be expressed in a postmitotic rest, which is preceded by the disregulation of stage-
cellular population that has inherited a methylated ge- specific genes. Aside from its known specific effects on
nome from cycling precursors. Even more puzzling, the monoallelic expression of imprinted genes, methyla-
most of the Dnmt1 protein is localized to the neuronal tion may serve to decrease general transcriptional
cytosol (Inano et al., 2000). Fan et al. (2001) utilized the “noise.” Why neurons should be particularly sensitive
identical cre-loxP system described above to inactivate to aberrant transcription of this order is unclear. Studies
Dnmt1 specifically in the CNS (Figure 2B). Mice showing are now appearing that look at the effects of hypometh-
a nearly complete loss of Dnmt1 in the CNS died shortly ylation upon global gene expression. Using oligonucleo-
after birth because of an unexplained respiratory failure. tide microarray analysis, fibroblast cultures deficient in
Although gross genomic hypomethylation could be de- Dnmt1 were shown to deregulate expression of up to
tected as early as 12.5 days postcoitum, an examination 10% of the examined genes (Jackson-Grusby et al.,
of the brain in newborns revealed no obvious develop- 2001). Similar studies comparing the misexpression of
mental abnormalities. However, and most curiously, genes in the CNS-specific Dnmt1 and Mecp2 knockouts
mice whose brains bore a low fraction of Dnmt1-nega- are doubtless underway.
tive cells showed a rapid loss of these cells, leading to Neither the Bird nor the Jaenisch laboratory reported
complete elimination of mutant neurons and glia 3 weeks the rapid postnatal loss of neurons from the Mecp2
after birth. Although it is totally unclear how gene-spe- knockout animals, suggesting that gross genomic hypo-
cific methylation patterns are altered in the neurons of methylation, as seen in the Dnmt1 knockout, may result
these mice, clearly methylation is needed for survival of in the misexpression of a larger subset of genes neces-
cells in the CNS, in a manner which seems to be cell sary for neuronal survival. Another possibility is a loss
autonomous. of chromosomal stability, as seen in ICF syndrome, a
A second knockout restricted to postmitotic neurons disease recently shown to be caused by mutations in
showed neither genomic hypomethylation nor any obvi- the DNMT3B gene (references in Robertson and Wolffe,
ous neuronal loss. Though this may seem unsurprising 2000). Embryonic stem cells deficient in Dnmt1 also
given that normal methylation patterns were in place show genomic instability, as seen in increased mutation
when the maintenance methyltransferase was removed, rates and somatic recombination (Chen et al., 1998).
there remains the question why neurons retain so much The structural stability that CpG methylation brings to
Dnmt1 protein. Under certain conditions, Dnmt1 pos- chromosomes may prove to be equally important in ex-
sesses de novo methylase activity. It should be stressed plaining the decreased viability and stunted morphology
that the two other functional methyltransferase genes, of neurons deficient in this process.
Dnmt3a and 3b, are known to encode de novo methyla-
tion activities and are also expressed, although at lower
Selected Readinglevels, in the brain. Although there is no evidence for an
involvement of methylation in plastic CNS processes,
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